Why the study?
Does combining clinical markers and preoperative dipyridamole-thallium imaging improve prediction of early postoperative cardiac ischemic events in patients undergoing major vascular surgery?
Does combining clinical markers and preoperative dipyridamole-thallium imaging improve prediction of early postoperative cardiac ischemic events in patients undergoing major vascular surgery?
Preoperative dipyridamole-thallium imaging is most useful for stratifying cardiac risk in vascular surgery patients deemed to be at intermediate risk by clinical evaluation alone, while it may be unnecessary for those at very high or low clinical risk.
May aid stratification in intermediate-risk vascular surgery patients; leaves open whether imaging-guided decisions improve outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eagle et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: